Bente Lund

Publikationer

Publikationer pr. år

2000 2020

• 22 Tidsskriftartikel
• 19 Konferenceabstrakt i tidsskrift
• 2 Poster
• 1 Konferenceartikel i tidsskrift

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2020

  Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies

  Vergote, I. B., Lund, B., Peen, U., Umajuridze, Z., Mau-Sorensen, M., Kranich, A., Van Nieuwenhuysen, E., Haslund, C., Nottrup, T., Han, S. N., Concin, N., Unger, T. J., Chai, Y., Au, N., Rashal, T., Joshi, A., Crochiere, M., Landesman, Y., Shah, J., Shacham, S. & 2 flere, Kauffman, M. & Mirza, M. R., feb. 2020, I : Gynecologic Oncology. 156, 2, s. 308-314 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
  6 Citationer (Scopus)
• 2019

  Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

  González-Martín, A., Pothuri, B., Vergote, I., DePont Christensen, R., Graybill, W., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., Baumann, K., Jardon, K., Redondo, A., Moore, R. G., Vulsteke, C., O'Cearbhaill, R. E., Lund, B., Backes, F., Barretina-Ginesta, P., Haggerty, A. F. & 11 flere, Rubio-Pérez, M. J., Shahin, M. S., Mangili, G., Bradley, W. H., Bruchim, I., Sun, K., Malinowska, I. A., Li, Y., Gupta, D., Monk, B. J. & PRIMA/ENGOT-OV26/GOG-3012 Investigators, 19 dec. 2019, I : The New England Journal of Medicine. 381, 25, s. 2391-2402 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • niraparib
  • Ovarian Neoplasms
  • Platinum
  • Homologous Recombination
  • Placebos
  180 Citationer (Scopus)

• Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

  Del Campo, J. M., Matulonis, U. A., Malander, S., Provencher, D., Mahner, S., Follana, P., Waters, J., Berek, J. S., Woie, K., Oza, A. M., Canzler, U., Gil-Martin, M., Lesoin, A., Monk, B. J., Lund, B., Gilbert, L., Wenham, R. M., Benigno, B., Arora, S., Hazard, S. J. & 1 flere, Mirza, M. R., 10 nov. 2019, I : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 32, s. 2968-2973 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  Åben adgang

  Fil

  • niraparib
  • Platinum
  • Ovarian Neoplasms
  • Drug Therapy
  • Patient Reported Outcome Measures
  16 Citationer (Scopus)

  11 Downloads (Pure)

• Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

  Mirza, M. R., Åvall Lundqvist, E., Birrer, M. J., dePont Christensen, R., Nyvang, G-B., Malander, S., Anttila, M., Werner, T. L., Lund, B., Lindahl, G., Hietanen, S., Peen, U., Dimoula, M., Roed, H., Ør Knudsen, A., Staff, S., Krog Vistisen, A., Bjørge, L., Mäenpää, J. U., AVANOVA investigators & 1 flere, Lund, B., okt. 2019, I : The Lancet. Oncology. 20, 10, s. 1409-1419 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • niraparib
  • Equivalence Trials
  • Bevacizumab
  • Platinum
  • Ovarian Neoplasms
  32 Citationer (Scopus)
• 2018

  Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

  Oza, A. M., Matulonis, U. A., Malander, S., Hudgens, S., Sehouli, J., Del Campo, J. M., Berton-Rigaud, D., Banerjee, S., Scambia, G., Berek, J. S., Lund, B., Tinker, A. V., Hilpert, F., Vázquez, I. P., D'Hondt, V., Benigno, B., Provencher, D., Buscema, J., Agarwal, S. & Mirza, M. R., 2018, I : The Lancet. Oncology. 19, 8, s. 1117-1125 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • niraparib
  • Ovarian Neoplasms
  • Placebos
  • Randomized Controlled Trials
  • Quality of Life
  37 Citationer (Scopus)
• 2016

  Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer

  Dahl Steffensen, K., Waldstrøm, M., Brandslund, I., Lund, B., Mejer Sørensen, S., Petzold, M. & Jakobsen, A., 2016, I : Oncology Letters. 11, 6, s. 3967-3974 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  Åben adgang
  10 Citationer (Scopus)

• Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

  du Bois, A., Kristensen, G., Ray-Coquard, I., Reuss, A., Pignata, S., Colombo, N., Denison, U., Vergote, I., Del Campo, J. M., Ottevanger, P., Heubner, M., Minarik, T., Sevin, E., de Gregorio, N., Bidziński, M., Pfisterer, J., Malander, S., Hilpert, F., Mirza, M. R., Scambia, G. & 8 flere, Meier, W., Nicoletto, M. O., Bjørge, L., Lortholary, A., Sailer, M. O., Merger, M., Harter, P. & AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium, jan. 2016, I : Lancet Oncology. 17, 1, s. 78-89 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • nintedanib
  • Ovarian Neoplasms
  • Placebos
  • Drug Therapy
  • Carboplatin
  121 Citationer (Scopus)
• 2015

  Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

  Oza, A. M., Cook, A. D., Pfisterer, J., Embleton, A., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Park-Simon, T-W., Rustin, G., Joly, F., Mirza, M. R., Plante, M., Quinn, M. S., Poveda, A., Jayson, G. C., Stark, D., Swart, A. M. & 5 flere, Farrelly, L., Kaplan, R., Parmar, M. K. B., Perren, T. J. & ICON7 trial investigators, aug. 2015, I : Lancet Oncology. 16, 8, s. 928-936 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  Åben adgang

  Fil

  • Bevacizumab
  • Ovarian Neoplasms
  • Drug Therapy
  • Survival
  • Gynecology
  338 Citationer (Scopus)

  187 Downloads (Pure)
• 2014

  A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

  Wang, Y., Herrstedt, J., Havsteen, H., Christensen, R. D., Mirza, M. R., Lund, B., Maenpaa, J. & Kristensen, G., 2014, I : B M C Cancer. 2014, 14, 937.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  Åben adgang
  5 Citationer (Scopus)

• Vellykket behandling af lokal avanceret, småcellet, neuroendokrint cervixkarcinom

  Rasmussen, L. B., Lindegaard, J. C., Lund, B., Grove, A. & Fokdal, L. U., 2014, I : Ugeskrift for Laeger. 176, 2 s., V06140374.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
• 2013

  Panitumumab and pegylated liposomal doxorubicin in platinum-resistant epithelial ovarian cancer with KRAS wild-type: the PaLiDo study, a phase II nonrandomized multicenter study

  Steffensen, K. D., Waldstrøm, M., Pallisgård, N., Lund, B., Bergfeldt, K., Wihl, J., Keldsen, N., Marth, C., Vergote, I. & Jakobsen, A., 1 jan. 2013, I : International Journal of Gynecological Cancer. 23, 1, s. 73-80 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Panitumumab
  • liposomal doxorubicin
  • Ovarian Epithelial Carcinoma
  • Platinum
  • Multicenter Studies
  18 Citationer (Scopus)

• Primært malignt melanom i vagina

  Kahr, H. S., Mejlgaard, E. & Lund, B., 14 jan. 2013, I : Ugeskrift for Laeger. 175, 3, s. 133-4 2 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Vagina
  • Melanoma
  • Pelvic Exenteration
  • Urethra
  • Recurrence
  3 Citationer (Scopus)
• 2012

  Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial

  Brundage, M., Gropp, M., Mefti, F., Mann, M. K., Lund, B., Gebski, V., Wolfram, G., Reed, N., Pignata, S., Ferrero, A., Brown, J. C., Eisenhauer, E. & Pujade-Lauraine, E., aug. 2012, I : Annals of Oncology. 23, 8, s. 2020-7 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Carboplatin
  • Platinum
  • Ovarian Neoplasms
  • liposomal doxorubicin
  • Quality of Life
  29 Citationer (Scopus)
• 2011

  A phase 3 trial of bevacizumab in ovarian cancer

  Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., du Bois, A., Sehouli, J., Kimmig, R., Stähle, A., Collinson, F., Essapen, S., Gourley, C., Lortholary, A., Selle, F., Mirza, M. R. & 7 flere, Leminen, A., Plante, M., Stark, D., Qian, W., Parmar, M. K. B., Oza, A. M. & ICON7 Investigators, 29 dec. 2011, I : The New England Journal of Medicine. 365, 26, s. 2484-96 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Bevacizumab
  • Ovarian Neoplasms
  • Survival
  • Disease Progression
  • Ovarian Epithelial Carcinoma
  1273 Citationer (Scopus)

• Improved Classification of Epithelial Ovarian Cancer: Results of 3 Danish Cohorts

  Steffensen, K. D., Waldstrom, M., Grove, A., Lund, B., Pallisgard, N. & Jakobsen, A., 16 sep. 2011, I : International Journal of Gynecological Cancer. 21, s. 1592-1600 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Ovarian Epithelial Carcinoma
  • Mutation
  • Neoplasms
  • Survival
  • Codon
  30 Citationer (Scopus)

• Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP)

  Jensen, I., Carl, J., Lund, B., Larsen, E. H. & Nielsen, J. N., 2011, I : Medical Dosimetry. 36, s. 130-7 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Prostatic Neoplasms
  • Radiotherapy
  • Conformal Radiotherapy
  • Neoplasms
  • Prostate
  10 Citationer (Scopus)
• 2010

  A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin

  Mirza, M. R., Lund, B., Lindegaard, J. C., Keldsen, N., Mellemgaard, A., Christensen, R. D. & Bertelsen, K., 1 okt. 2010, I : Gynecologic Oncology. 119, s. 26-31 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • liposomal doxorubicin
  • Ovarian Epithelial Carcinoma
  • Combination Drug Therapy
  • Drug Therapy
  • Therapeutics
  11 Citationer (Scopus)
• 2006

  Automated detection of a prostate Ni-Ti stent in electronic portal images.

  Carl, J. H., Nielsen, H., Nielsen, J., Lund, B. & Larsen, E. H., 2006, I : Medical Physics. 33, 12, s. 4600-4605 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  Åben adgang

  Fil

  • titanium nickelide
  • Stents
  • Prostate
  • Radiotherapy
  • Uncertainty
  3 Citationer (Scopus)

  432 Downloads (Pure)

• Feasibility study using a Ni-Ti stent and electronic portal imaging to localize the prostate during radiotherapy.

  Carl, J. H., Lund, B., Larsen, E. H. & Nielsen, J., 2006, I : Radiotherapy and Oncology. 78, s. 199-206

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  16 Citationer (Scopus)
• 2005

  Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG Intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) comparing TCG with standard TC

  Bois, A. D., Sehouli, J., Lund, B., Joly, E., Huober, J., Jensen, TS., Levy, E., Heilmann, V., Boman, K., Hardy-Bessard, AC., Burges, A., Maenpaa, J., Pujade-Lauraine, E., Pfisterer, J., Gropp, M., Staehle, A., Wimberger, P., Jackisch, C., Schmalfeldt, B., Belau, A. & 5 flere, Loibl, S., Wollschlaeger, K., Canzler, U., Rochon, J. & GINE, GCIG. I. AGO-OVAR. NSGO., 1 nov. 2005, I : International Journal of Gynecological Cancer. 15, Suppl. 3, s. 224-225 2 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  5 Citationer (Scopus)

• The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark

  Andersen, E. S., Knudsen, A., Svarrer, T., Lund, B., Nielsen, K., Grove, A. & Tetsche, M. S., 2005, I : Gynecologic Oncology. 99, 3, s. 552-556 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  26 Citationer (Scopus)
• 2001

  Multicenter phase II study of gemcitabine in previously untreated patients with advanced epithelial ovarian cancer

  Underhill, CR., Parnis, FX., Highley, MS., Ahern, J., Harper, PG., Hansen, H., Lund, B., Dombernowsky, P., Hirsch, F., Hansen, M., Carmichael, J. & Williams, H. C., 1 sep. 2001, I : Anti-Cancer Drugs. 12, 8, s. 647-652 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
  12 Citationer (Scopus)